Downregulation of IL-1β expression as early as 3 h after rLrIL-10 treatment is expected as IL-1β is one of the early response proinflammatory cytokines that enables organisms to respond to infections, inducing an inflammatory cascade, along with other defensive responses. The gene discussed is IL1B; the disease is infection.